Altwegg R, et al. - The target of the researchers was to contemplate the safety and effectiveness of anti-TNF therapy in patients with inflammatory bowel disease (IBD) after a liver transplantation (LT) for primary sclerosing cholangitis (PSC). It was discovered that anti-TNF therapy was effective for treating IBD after LT for PSC. Nevertheless, as specified in the current guidelines, colonoscopic annual surveillance was suggested after LT since 17% of the patients developed colorectal cancer during the follow-up.